Loading... Please wait...
About Us
Contact Us
Privacy Policy
Sign in
or
Create an account
My Account
View Basket
Checkout
Search
Home
Report Subject
Technology/Digital Health
Browse by
Biosimilar Index
Dossier
FirstView
FirstView NPS+
FirstWord Pharma
Therapy Trends
Therapy Trends Updates
Latest Reports
Therapy Area Reports
Report Subject
Emerging Markets
Generics/Biosimilars
Market Access
Medical Affairs
Pharma Marketing
Pharma Sales
Technology/Digital Health
Orphan Drugs
Sort by:
Featured Items
Newest Items
Bestselling
Alphabetical: A to Z
Alphabetical: Z to A
Next »
Pages:
1
2
3
Learn More
Big Data and AI in Market Access [2020]
How is big data+AI technology driving market access strategy and practice? Juggling the demands of multiple stakeholders for evidence of utility and value, while harnessing the insights from an ever-growing number of...
Compare
Learn More
Ambitions in Health: Tech Giants [2020]
How have payers met the challenge of COVID-19 and how do they see the future? The impact of the COVID-19 pandemic has been especially felt in respiratory disease and presents a unique set of challenges for payers. From...
Compare
Learn More
Pricing and Reimbursement in Respiratory: Payer Views [2020]
How have payers met the challenge of COVID-19 and how do they see the future? The impact of the COVID-19 pandemic has been especially felt in respiratory disease and presents a unique set of challenges for payers. From...
Compare
Learn More
Innovations in Drug Pricing and Reimbursement 2020
Evaluating new digital tools and deal structures to drive better commercial outcomes What are the trends and technologies that could deliver a better understanding of payers' needs and build improved evidence of value?...
Compare
Learn More
Data Driven Customer Relationship Management In Pharma
Experts agree data-driven CRM holds the key to achieving true customer centricity It's already known that data-driven CRM improves and drives forward the customer experience. Pharma has a powerful tool at its disposal,...
Compare
Learn More
Real World Data for Orphan Drugs: Meeting the Data Analysis Challenge
Creating meaningful insights from diverse data sources The explosion in real-world data (RWD) from digital platforms is creating new insights into the understanding of rare diseases and patient experiences. The value...
Compare
Learn More
Pricing and Reimbursement in Neurology: Payer Views [2020]
Understanding payer challenges in Multiple Sclerosis, Epilepsy, Migraine and Neurodegenerative disease Despite wide unmet need across a number of neurological conditions, no really high impact breakthrough therapies...
Compare
Learn More
Value-based Healthcare in a Digital World [2020]
Accelerated use of digital technology challenges pharma to rethink its approach COVID-19 has radically increased the use of digital technology by patients and HCPs but how does that play into the trend to value-based...
Compare
Learn More
Orphan Drugs: Benchmarking Commercial Models [2020]
What are the essential factors for orphan drug success? Several orphan drugs have proven to be commercial winners, so what are the key ingredients for success in 2020? For example, as the sector has evolved the power...
Compare
Learn More
MSL-KOL Engagement [2020]
Maintaining and growing KOL relationships in pandemic lockdown At a stroke, the COVID-19 pandemic shut down MSL's principal KOL engagement channels. With face-to-face interactions on hold, MSLs have turned to...
Compare
Learn More
The Rise of ICER – The Payer Perspective
Payers reveal where ICER is really impacting pharma/payer relations How is the Institute for Clinical and Economic Review (ICER) influencing payer behavior? ICER's evidence and price benchmarking data are valued by...
Compare
Learn More
The State of Pharma Digital Transformation 2020
How far has pharma come, and what does it still need to do, to realize the full benefits of digital technology across its business? The COVID-19 pandemic may have spurred rapid expansion in the use of digital tools but...
Compare
Learn More
Smart Pharma Sales: How Digital is Reinventing the Process
Post COVID-19, pharma's opportunity is to build on the impact of digital technology to revolutionize its sales practice and engagement strategies The COVID-19 pandemic has radically reshaped how pharma does sales and...
Compare
Learn More
Engaging with ICER: Lessons and insights for pharma
ICER is here to stay so how best can industry engage for its benefit? The Institute for Clinical and Economic Review (ICER) is gaining a growing reputation with US payers. While ICER's drug assessments are advisory, and...
Compare
Learn More
Digital Health and the Management of Chronic Disease
Essential strategies for developing next phase digital health solutions The COVID-19 pandemic has accelerated and elevated the role of digital health and could serve as a turning point for digital platforms to become...
Compare
Learn More
Measuring Digital Success in Pharma: Essential KPIs
Which KPI's should pharma be using to assess the success of its digital technology investments? The Covid-19 pandemic is fundamentally changing working practice and driving immediate expansion of digital solutions. But...
Compare
Next »
Pages:
1
2
3
About Us
Contact Us
Privacy Policy
customer.service@firstwordpharma.com
All Contents Copyright © 2021 Doctor's Guide Publishing Limited All Rights Reserved